These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11718836)

  • 1. Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration.
    Mao L; Lau YS; Petroske E; Wang JQ
    Brain Res Dev Brain Res; 2001 Nov; 131(1-2):57-65. PubMed ID: 11718836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection.
    Kay JN; Blum M
    Dev Neurosci; 2000; 22(1-2):56-67. PubMed ID: 10657698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
    Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
    Watanabe Y; Kato H; Araki T
    Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
    Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F
    J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G; Møller A; Rosén L; Janson AM; Agnati LA; Goldstein M; Ogren SO; Pettersson RF; Fuxe K
    Exp Brain Res; 1993; 97(1):145-58. PubMed ID: 7907549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
    Chang FW; Wang SD; Lu KT; Lee EH
    Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Metab Brain Dis; 2003 Jun; 18(2):139-46. PubMed ID: 12822832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP.
    Liu L; Hsu SS; Kalia SK; Lozano AM
    Brain Res; 2003 Dec; 994(2):243-52. PubMed ID: 14642650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliogenesis in the striatum of the adult rat: alteration in neural progenitor population after psychostimulant exposure.
    Mao L; Wang JQ
    Brain Res Dev Brain Res; 2001 Sep; 130(1):41-51. PubMed ID: 11557092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.
    Himeda T; Watanabe Y; Tounai H; Hayakawa N; Kato H; Araki T
    J Neural Transm (Vienna); 2006 Dec; 113(12):1887-94. PubMed ID: 16736245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.